Tuesday, May 23, 2017 8:43:27 AM
PLX - .78 Pre-market at .8429/.8679
Protalix BioTherapeutics Announces Presentation of Phase II Clinical Trial Results for alidornase alfa in Cystic Fibrosis at the 40th European Cystic Fibrosis Society Conference
Protalix BioTherapeutics, Inc.: Manor Moshe (Director, President & CEO) Buys 50,000 @ Avg Price: $0.81 (Form4)
Protalix BioTherapeutics Announces Presentation of Phase II Clinical Trial Results for alidornase alfa in Cystic Fibrosis at the 40th European Cystic Fibrosis Society Conference
Protalix BioTherapeutics, Inc.: Manor Moshe (Director, President & CEO) Buys 50,000 @ Avg Price: $0.81 (Form4)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
